Company intelligence / Profile preview

VEB Deutsches Hydrierwerk Rodleben

Dessau-Roßlau/Rodleben, Saxony-Anhalt, Germany

Ownership: Private
Development stage: Other

Overview

VEB Deutsches Hydrierwerk Rodleben was a state-owned industrial chemical manufacturer in the former German Democratic Republic (East Germany), known for its expertise in catalytic hydrogenation processes. It is historically notable for synthesizing trapidil—a vasodilator and anti-platelet agent—in 1964[1], and for operating one of the largest continuous catalytic fixed-bed plants for glucose hydrogenation to produce sorbitol using copper/nickel catalysts[2]. The company did not operate as a pharmaceutical or biotech firm but supplied intermediates and bulk chemicals relevant to those industries.

Industry: Chemicals & Materials

Partnerships

Not specified; operated as part of GDR's planned economy structure.

Beyond the preview

Go deeper on VEB Deutsches Hydrierwerk Rodleben.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VEB Deutsches Hydrierwerk Rodleben.